SI-BONE’s iFuse Implant System® has been utilized in more than 40,000 sacroiliac joint fusion procedures by more than 1,900 surgeons worldwide since launch in 2009. Company leadership estimates that 279,000 new patients in the U.S. each year may become candidates for an iFuse procedure.
Earlier this month, 5-year follow-up results from LOIS (Long Term Outcomes from INSITE and SIFI), a long-term prospective study, were submitted for publication. The results demonstrated durability of the clinical benefit related to the procedure.
SI-BONE's iFuse Implant System® has been utilized in more than 40,000 sacroiliac joint fusion procedures by more than 1,900 surgeons worldwide since launch in 2009. Company leadership estimates that 279,000 new patients in the U.S. each year may become candidates for an iFuse procedure.
Earlier this month, 5-year follow-up results from LOIS...
SI-BONE’s iFuse Implant System® has been utilized in more than 40,000 sacroiliac joint fusion procedures by more than 1,900 surgeons worldwide since launch in 2009. Company leadership estimates that 279,000 new patients in the U.S. each year may become candidates for an iFuse procedure.
Earlier this month, 5-year follow-up results from LOIS (Long Term Outcomes from INSITE and SIFI), a long-term prospective study, were submitted for publication. The results demonstrated durability of the clinical benefit related to the procedure.
Copy to clipboard 
